UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2018-07, Vol.16 (7), p.1437-1441

2018

Volltextzugriff (PDF)

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-01, Vol.17 (1), p.2-10

2011

Volltextzugriff (PDF)

Pharmacokinetics of VWF/FVIII concentrates is a very intricate matter

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-11, Vol.17 (6), p.846-848

MORFINI, M.

2011

Volltextzugriff (PDF)

Efficacy and safety of secondary prophylactic vs. on‐demand sucrose‐formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13‐month crossover study

Journal of thrombosis and haemostasis, 2010-01, Vol.8 (1), p.83-89

2010

Volltextzugriff (PDF)

Articular status of haemophilia patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-11, Vol.14 (s6), p.20-22

MORFINI, M.

2008

Volltextzugriff (PDF)

European Study on Orthopaedic Status of haemophilia patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-09, Vol.13 (5), p.606-612

2007

Volltextzugriff (PDF)

Ultrasound detects joint damage and bleeding in haemophilic arthropathy: a proposal of a score

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-01, Vol.17 (1), p.112-117

2011

Volltextzugriff (PDF)

Pharmacokinetics of plasma-derived vs. recombinant FVIII concentrates: a comparative study

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-03, Vol.21 (2), p.204-209

2015

Volltextzugriff (PDF)

Population pharmacokinetics of a new long‐acting recombinant coagulation factor IX albumin fusion protein for patients with severe hemophilia B

Journal of thrombosis and haemostasis, 2016-11, Vol.14 (11), p.2132-2140

2016

Volltextzugriff (PDF)

Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.730-738

2016

Volltextzugriff (PDF)

Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate

European journal of pharmaceutical sciences, 2020-10, Vol.153, p.105485, Article 105485

2020

Volltextzugriff (PDF)

Mortality and causes of death in Italian persons with haemophilia, 1990-2007

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-05, Vol.16 (3), p.437-446

2010

Volltextzugriff (PDF)

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1), p.96-102

2016

Volltextzugriff (PDF)

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.736-743

2013

Volltextzugriff (PDF)

Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-07, Vol.22 (4), p.537-542

2016

Volltextzugriff (PDF)

Pharmacokinetics and safety of a 270 mcg kg−1 dose of room temperature stable recombinant activated factor VII in patients with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-11, Vol.17 (6), p.860-866

2011

Volltextzugriff (PDF)

Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-11, Vol.17 (6), p.854-859

2011

Volltextzugriff (PDF)

Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey

Journal of thrombosis and haemostasis, 2004-07, Vol.2 (7), p.1096-1103

2004

Volltextzugriff (PDF)

Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers

Journal of thrombosis and haemostasis, 2012-01, Vol.10 (1), p.90-95

2012

Volltextzugriff (PDF)

Viscosupplementation in haemophilic arthropathy: a long-term follow-up study

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-05, Vol.18 (3), p.e210-e214

2012

Volltextzugriff (PDF)

Inhibitors in haemophilia B: the Italian experience

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.686-690

2013

Volltextzugriff (PDF)

Italian Registries on Bleeding Disorders

Clinical pharmacology and therapeutics, 2016-03, Vol.99 (3), p.271-272

2016

Volltextzugriff (PDF)

Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-01, Vol.19 (1), p.126-133

2013

Volltextzugriff (PDF)

FRI0488 Ultrasound detects joint damage and bleeding in haemophilic arthropathy: the utility of a score

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A540-A540

2013

Volltextzugriff (PDF)

AB0959 The Role of Ultrasonography in the Early Diagnosis of Arthropathy in A not Target Joint of Haemophiliacs

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.1117-1117

2014

Volltextzugriff (PDF)

1 – 25 von 300

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(278)
Mit Volltextzugriff
(215)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia

Pharmacokinetics of VWF/FVIII concentrates is a very intricate matter

Efficacy and safety of secondary prophylactic vs. on‐demand sucrose‐formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13‐month crossover study

Articular status of haemophilia patients with inhibitors

European Study on Orthopaedic Status of haemophilia patients with inhibitors

Ultrasound detects joint damage and bleeding in haemophilic arthropathy: a proposal of a score

Pharmacokinetics of plasma-derived vs. recombinant FVIII concentrates: a comparative study

Population pharmacokinetics of a new long‐acting recombinant coagulation factor IX albumin fusion protein for patients with severe hemophilia B

Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A

Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate

Mortality and causes of death in Italian persons with haemophilia, 1990-2007

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study

Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study

Pharmacokinetics and safety of a 270 mcg kg−1 dose of room temperature stable recombinant activated factor VII in patients with haemophilia

Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A

Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey

Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers

Viscosupplementation in haemophilic arthropathy: a long-term follow-up study

Inhibitors in haemophilia B: the Italian experience

Italian Registries on Bleeding Disorders

Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patients

FRI0488 Ultrasound detects joint damage and bleeding in haemophilic arthropathy: the utility of a score

AB0959 The Role of Ultrasonography in the Early Diagnosis of Arthropathy in A not Target Joint of Haemophiliacs

Suchergebnisse filtern